Time Is Running Out: Is Your FQHC Registered with Beacon?

FQHC 340B 340B Rebate Model FQHC Pharmacy 340B Rebate Model Pilot

The start of 2026 is approaching quickly, and with it comes a major operational change for some Federally Qualified Health Centers. On January 1, 2026, the 340B Rebate Model Pilot officially goes live. For health centers that dispense certain high-cost medications, preparation is no longer optional. One of the most important steps is registering with Beacon.

Many FQHC leaders are still unaware that this registration is required for participation in the pilot. Others are aware but have not yet completed the process. With only weeks remaining, now is the time to act.

What Is Beacon?

Beacon is the platform used to manage manufacturer rebate submissions under the new pilot program. It supports the operational shift introduced by HRSA's 340B Rebate Model Pilot, which tests a different approach to handling 340B discounts for certain drugs.

Under the traditional 340B model, covered entities receive discounted pricing at the point of sale. Under the pilot, that changes. Health centers pay Wholesale Acquisition Cost upfront for select medications and then submit claims through Beacon to receive rebates directly from participating manufacturers.

This shift makes Beacon a required part of the workflow for any health center participating in the pilot.

Who Needs to Register?

Beacon registration is required for any FQHC or covered entity that participates in the 340B Rebate Model Pilot and dispenses at least one of the approved pilot drugs. This applies even if the drug volume is small. Dispensing a single pilot drug is enough to trigger the requirement.

The pilot does not apply to all 340B medications. However, for health centers that do dispense pilot drugs, Beacon registration is essential to ensure rebates can be submitted and paid.

Drugs Included in the Pilot

As of now, the pilot includes a defined list of medications. These are subject to change over time, but currently include the following examples.

  • Eliquis

  • Enbrel

  • Farxiga

  • Imbruvica

  • Januvia

  • Jardiance

  • Stelara

  • Xarelto

  • Select NovoLog and Fiasp products

Because this list may expand, health centers should continue monitoring HRSA guidance even after initial registration is complete.

Why Registration Cannot Wait

Registering with Beacon before January 1, 2026, is not just a compliance step. It is a financial and operational safeguard.

Registration allows time to verify banking information for ACH payments, which is required to receive manufacturer rebates. It also gives pharmacy and finance teams time to understand the new process before claims begin flowing.

Most importantly, early registration helps prevent cash flow disruptions. Under the pilot, pharmacies will be paying full WAC pricing upfront. Any delay in rebate processing could tie up significant funds in the first quarter of 2026. For many FQHCs, even short delays could have a real impact on pharmacy operations and overall financial stability.

What You Need to Register

Beacon registration requires several standard organizational documents. These must be current and consistent across all files submitted.

Health centers should expect to provide their EIN, CP 575 letter, Articles of Incorporation, an updated W-9 using the March 2024 revision, and a certified bank letter dated within the last 180 days.

Inconsistencies between documents are one of the most common reasons for delays, so careful review before submission is critical.

How Long the Process Takes

Once submitted, Beacon registration can take up to five business days for approval. If documents are missing or need correction, the process can take longer.

Waiting until late December increases the risk that approval will not be completed before the pilot goes live. That timing could delay rebate submissions during the earliest and most critical phase of the program.

The Risk of Waiting Too Long

Delaying registration creates avoidable risks. Rebates cannot be processed without an approved Beacon account. Pharmacy teams may be forced to learn a new workflow under pressure. Finance teams may face unexpected timing gaps between drug purchase and rebate receipt.

All of these issues are preventable with early preparation.

Some Final Thoughts

The 340B Rebate Model Pilot represents a meaningful shift in how certain drugs are handled within FQHC pharmacy operations. Beacon is the system that enables participation.

If your health center dispenses any of the pilot drugs, Beacon registration should be treated as a top operational priority. Assign ownership now, gather documents early, and complete the process well before January 1, 2026.

This is not just about compliance. It is about protecting pharmacy cash flow, supporting staff readiness, and ensuring a smooth transition into the new year.

Health Center Vendor Network exists to help Federally Qualified Health Centers connect with vendors who understand community health and are prepared for where interoperability is heading, not just where it’s been.